Fortress Biotech
FBIO
#9572
Rank
NZ$0.18 B
Marketcap
NZ$5.66
Share price
-2.10%
Change (1 day)
70.77%
Change (1 year)

Earnings for Fortress Biotech (FBIO)

Earnings in 2026 (TTM): NZ$0.23 Billion

According to Fortress Biotech 's latest financial reports the company's current earnings are NZ$66.16 Million. In 2025 the company made an earning of -NZ$58.37 Million, an increase over its 2024 earnings that were of -NZ$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fortress Biotech from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.23 B-498.6%
2025 -NZ$58.37 Million-72.02%
2024 -NZ$0.21 Billion-21.6%
2023 -NZ$0.27 Billion-28.03%
2022 -NZ$0.37 Billion29.88%
2021 -NZ$0.29 Billion59.8%
2020 -NZ$0.18 Billion1.17%
2019 -NZ$0.18 Billion-19.84%
2018 -NZ$0.22 Billion28.99%
2017 -NZ$0.18 Billion37.92%
2016 -NZ$0.13 Billion32.31%
2015 -NZ$93.3 Million164.31%
2014 -NZ$35.3 Million-45.14%
2013 -NZ$64.34 Million37.55%
2012 -NZ$46.78 Million-22.91%
2011 -NZ$60.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Veracyte
VCYT
NZ$0.15 B-31.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.21 Billion-188.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-NZ$58.92 Million-125.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
-NZ$58.68 Million-125.43%๐Ÿ‡บ๐Ÿ‡ธ USA